Importantly, elevated Fcgr2b expression has been observed on CD8+ tumor‐infiltrating lymphocytes in patients with myeloma and in patients with SARS‐CoV‐2 (Morris et al. 2025; Bennion et al. 2023; Baecher and Ford 2021). This evidence concerns the gene FCGR2B and neoplasm.